From: Ethical issues relating to renal transplantation from prediabetic living donor
Author and publication year | Study type and follow − up period | Place and population of study | Form of valuation | Results |
---|---|---|---|---|
Fehrman-Ekholm et al. 2001 [13] | Cohort study with a follow − up of 12 years (April 1964 − December 1995) | Sweden | Normal initial OGTT | Six developed T2DM |
348 relative living donors (93.5% inbreeding) | ||||
Aroda et al. 2008 [8] | Review study. Information from the National Centre for Chronic Disease Prevention and Health Promotion (2008) | USA | Fasting plasma glucose levels and OGTT | Risk to develop T2DM: |
National Study | 0.7% normoglicemic, and | |||
5 − 10% IFG and IGT | ||||
Nichols et al. 2007 [14] | Cohort studies with a follow time of nine years (January 1994 − December 2003) | USA | Fasting plasma glucose levels between | From people with glucose levels between 100–109 mg/dL, 8.1% developed T2DM. |
5,452 members from the Kaiser Permanente Northwest | ||||
From people with glucose levels between 110–125 mg/dl, 24.3% developed T2DM | ||||
100–109 mg/dl and 110–125 mg/dl | ||||
Fox et al. | Cohort studies. | USA | Fasting plasma glucose levels and OGTT | Risk of 65% to develop CKF on people with IFG and IGT in comparison with control group |
Framingham (Follow − up) | Initial time: 1991–1995 Follow − up period: 1998 − 2001 | 2,398 persons | ||
2005 [11] | ||||
Azar et al. 2007 [15] | Cohort study with a follow − up of three years | Iran | Clinical and biochemical record | 55% presented hypertension. |
Tabriz Medical Sciences University | ||||
7% Increased creatinine concentrations | ||||
86 living donors, no related | 10% presented severe depression |